Armata Pharmaceuticals (ARMP) Interest & Investment Income (2018 - 2024)
Armata Pharmaceuticals' (ARMP) quarterly Interest & Investment Income came in at $221000.0 in Q2 2024, up 380.43% year-on-year from $46000.0 in Q3 2023, and up 325.0% quarter-over-quarter from $52000.0 in Q1 2024.
Armata Pharmaceuticals (ARMP) Interest & Investment Income (2018 - 2024) Analysis & Trends
Armata Pharmaceuticals has disclosed Interest & Investment Income across 7 years of filings, most recently posting $221000.0 for Q2 2024.
- Interest & Investment Income for Q2 2024 came in at $221000.0, up 380.43% year-over-year; the trailing twelve-month figure through Jun 2024 was $388000.0 (up 345.98% YoY), and the FY2023 annual result was $179000.0, up 517.24% from the prior year.
- Interest & Investment Income came in at $221000.0 for Q2 2024 at Armata Pharmaceuticals, up from $52000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $221000.0 in Q2 2024 to a low of $1000.0 in Q4 2021.
- The 5-year median for Interest & Investment Income is $11500.0 (2022), against an average of $32125.0.
- Across the five-year window, Interest & Investment Income sank 95.83% in 2020 and soared 1700.0% in 2023, its largest moves.
- Armata Pharmaceuticals' Interest & Investment Income stood at $4000.0 in 2020, then slumped by 75.0% to $1000.0 in 2021, then soared by 1300.0% to $14000.0 in 2022, then soared by 385.71% to $68000.0 in 2023, then surged by 225.0% to $221000.0 in 2024.
- The last three Interest & Investment Income figures came in at $221000.0 (Q2 2024), $52000.0 (Q1 2024), and $68000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 221,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 28,000.00 |
| Mar 31, 2019 | 48,000.00 |